https://pubmed.ncbi.nlm.nih.gov/27882542/
A novel gain-of-function mutation in ORAI1 causes late-onset tubular aggregate myopathy and congenital miosis
- PMID: 27882542
- DOI: 10.1111/cge.12888
Abstract
We present three members of an Italian family affected by tubular aggregate myopathy (TAM) and congenital miosis harboring a novel missense mutation in ORAI1. All patients had a mild, late onset TAM revealed by asymptomatic creatine kinase (CK) elevation and congenital miosis consistent with a Stormorken-like Syndrome, in the absence of thrombocytopathy. Muscle biopsies showed classical histological findings but ultrastructural analysis revealed atypical tubular aggregates (TAs). The whole body muscle magnetic resonance imaging (MRI) showed a similar pattern of muscle involvement that correlated with clinical severity. The lower limbs were more severely affected than the scapular girdle, and thighs were more affected than legs. Molecular analysis revealed a novel c.290C>G (p.S97C) mutation in ORAI1 in all affected patients. Functional assays in both human embryonic kidney (HEK) cells and myotubes showed an increased rate of Ca2+ entry due to a constitutive activation of the CRAC channel, consistent with a 'gain-of-function' mutation. In conclusion, we describe an Italian family harboring a novel heterozygous c.290C>G (p.S97C) mutation in ORAI1 causing a mild- and late-onset TAM and congenital miosis via constitutive activation of the CRAC channel. Our findings extend the clinical and genetic spectrum of the ORAI1-related TAM.
Keywords: CRAC channel; ORAI1; Stormorken syndrome; congenital miosis; muscle MRI; tubular aggregate myopathy.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Similar articles
- Activating mutations in STIM1 and ORAI1 cause overlapping syndromes of tubular myopathy and congenital miosis.Proc Natl Acad Sci U S A. 2014 Mar 18;111(11):4197-202. doi: 10.1073/pnas.1312520111. Epub 2014 Mar 3.PMID: 24591628 Free PMC article.
- CRAC channels and disease - From human CRAC channelopathies and animal models to novel drugs.Cell Calcium. 2019 Jun;80:112-116. doi: 10.1016/j.ceca.2019.03.004. Epub 2019 Mar 11.PMID: 31009822 Free PMC article. Review.
- ORAI1 Mutations with Distinct Channel Gating Defects in Tubular Aggregate Myopathy.Hum Mutat. 2017 Apr;38(4):426-438. doi: 10.1002/humu.23172. Epub 2017 Feb 2.PMID: 28058752
- Gain-of-function mutations in STIM1 and ORAI1 causing tubular aggregate myopathy and Stormorken syndrome.Cell Calcium. 2018 Dec;76:1-9. doi: 10.1016/j.ceca.2018.07.008. Epub 2018 Sep 3.PMID: 30243034 Review.
- Dominant mutations in ORAI1 cause tubular aggregate myopathy with hypocalcemia via constitutive activation of store-operated Ca²⁺ channels.Hum Mol Genet. 2015 Feb 1;24(3):637-48. doi: 10.1093/hmg/ddu477. Epub 2014 Sep 16.PMID: 25227914
Cited by 9 articles
- Molecular Choreography and Structure of Ca2+ Release-Activated Ca2+ (CRAC) and KCa2+ Channels and Their Relevance in Disease with Special Focus on Cancer.Membranes (Basel). 2020 Dec 15;10(12):425. doi: 10.3390/membranes10120425.PMID: 33333945 Free PMC article. Review.
- STIM1/ORAI1 Loss-of-Function and Gain-of-Function Mutations Inversely Impact on SOCE and Calcium Homeostasis and Cause Multi-Systemic Mirror Diseases.Front Physiol. 2020 Nov 4;11:604941. doi: 10.3389/fphys.2020.604941. eCollection 2020.PMID: 33250786 Free PMC article. Review.
- A luminal EF-hand mutation in STIM1 in mice causes the clinical hallmarks of tubular aggregate myopathy.Dis Model Mech. 2019 Dec 3;13(2):dmm041111. doi: 10.1242/dmm.041111.PMID: 31666234 Free PMC article.
- Critical parameters maintaining authentic CRAC channel hallmarks.Eur Biophys J. 2019 Jul;48(5):425-445. doi: 10.1007/s00249-019-01355-6. Epub 2019 Mar 21.PMID: 30903264 Free PMC article. Review.
- Investigation of novel variations of ORAI1 gene and their association with Kawasaki disease.J Hum Genet. 2019 Jun;64(6):511-519. doi: 10.1038/s10038-019-0588-2. Epub 2019 Mar 11.PMID: 30853710
Nessun commento:
Posta un commento